Discovery of a cobalt complex with high MEK1 binding affinity |
| |
Authors: | Hongyue Li Tongliang Zhou Hui Liu Fengrong Xu Yan Niu Chao Wang Lei Liang Ping Xu |
| |
Affiliation: | Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China |
| |
Abstract: | A series of Schiff base ligands (L1–L5) and their cobalt(II) complexes (1–5) were designed and synthesized for MEK1 binding experiment. The biological evaluation results showed that Bis(N,N′-disalicylidene)-3,4-phenylenediamine-cobalt(II) 1 and Bis(N,N′-disalicylidene)-1,2-cyclohexanediamine-cobalt(II) 2 are much more effective than the parent Schiff bases (L1 and L2). Importantly, 2 exhibited MEK1 binding affinity with IC5071 nM, which is so far the best result for metal complexes and more potent than U0126 (7.02 μM) and AZD6244 (2.20 μM). Docking study was used to elucidate the binding modes of complex 2 with MEK1. Thus cobalt(II) complex 2 may be further developed as a novel MEK1 inhibitor. |
| |
Keywords: | MEK Kinase Schiff base Cobalt complex Docking |
本文献已被 ScienceDirect 等数据库收录! |
|